Literature DB >> 31345648

Women with coronary microvascular dysfunction and no obstructive coronary artery disease have reduced exercise capacity.

Daria Frestad Bechsgaard1, Jens Dahlgaard Hove2, Hannah Elena Suhrs3, Kira Bang Bové3, Persia Shahriari4, Ida Gustafsson5, Eva Prescott6.   

Abstract

BACKGROUND: Both coronary microvascular dysfunction (CMD) and reduced exercise capacity are associated with adverse cardiovascular prognosis. The association between CMD and cardiopulmonary exercise testing (CPET) derived exercise capacity in symptomatic individuals without obstructive coronary artery disease (CAD) is not clear. We investigated whether exercise capacity was reduced in women with angina, CMD and no obstructive CAD compared with sex-matched controls. Furthermore, we assessed the association between CMD and other CPET-derived variables.
METHODS: All participants underwent transthoracic Doppler echocardiography of the left anterior descending artery with dipyridamole-induced vasodilation and CPET using ergometer cycle with an incremental test protocol.
RESULTS: We included 99 women with angina and no obstructive CAD (patients) and 27 asymptomatic women (controls), age (mean ± standard deviation) 61 ± 10 and 58 ± 10 years, respectively. Patients had a higher burden of risk factors compared with controls, while the weekly physical activity level was comparable between the groups (p = 0.72). CMD was present in 27 (27%) patients and 5 (19%) controls. Peak VO2 was significantly reduced in patients with CMD compared with controls with normal coronary microvascular function ((median (IQR) 17.3 (15.5-21.3) vs. 27.3 (21.6-30.8) ml/kg/min; age-adjusted p = 0.001), independent of cardiovascular risk factors (p = 0.041). Presence of CMD in symptomatic women was also associated with diminished heart rate reserve (p < 0.001) and blunted heart rate recovery.
CONCLUSIONS: Women with angina, CMD and no obstructive CAD have markedly reduced exercise capacity compared with sex-matched controls. Moreover, combination of angina and CMD is associated with impaired heart rate response and heart rate recovery.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Year:  2019        PMID: 31345648     DOI: 10.1016/j.ijcard.2019.07.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease.

Authors:  Diana M Lopez; Sanjay Divakaran; Ankur Gupta; Navkaranbir S Bajaj; Michael T Osborne; Wunan Zhou; Jon Hainer; Courtney F Bibbo; Hicham Skali; Sharmila Dorbala; Viviany R Taqueti; Ron Blankstein; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2021-08-18

2.  Rationale and Study Design of Differences in Cardiopulmonary Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition in Patients with Suspected Heart Failure with Preserved Ejection Fraction.

Authors:  So Ree Kim; Dong-Hyuk Cho; Mi-Na Kim; Seong-Mi Park
Journal:  Int J Heart Fail       Date:  2021-09-14

3.  Functional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction.

Authors:  Christopher L Schumann; Roshin C Mathew; John-Henry L Dean; Yang Yang; Pelbreton C Balfour; Peter W Shaw; Austin A Robinson; Michael Salerno; Christopher M Kramer; Jamieson M Bourque
Journal:  JACC Cardiovasc Imaging       Date:  2021-04-14

4.  Multiparametric exercise stress cardiovascular magnetic resonance in the diagnosis of coronary artery disease: the EMPIRE trial.

Authors:  Calvin W L Chin; Stuart A Cook; Thu-Thao Le; Briana W Y Ang; Jennifer A Bryant; Chee Yang Chin; Khung Keong Yeo; Philip E H Wong; Kay Woon Ho; Jack W C Tan; Phong Teck Lee
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-04       Impact factor: 5.364

Review 5.  Gender-Related Differences in Chest Pain Syndromes in the Frontiers in CV Medicine Special Issue: Sex & Gender in CV Medicine.

Authors:  Puja K Mehta; Janet Wei; Chrisandra Shufelt; Odayme Quesada; Leslee Shaw; C Noel Bairey Merz
Journal:  Front Cardiovasc Med       Date:  2021-11-17

6.  Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial.

Authors:  Kira Bang Bove; Malin Nilsson; Lene Rørholm Pedersen; Nicolai Mikkelsen; Hannah Elena Suhrs; Arne Astrup; Eva Prescott
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.